Lendormin® | boehringer-ingelheim (Brotizolam 0.25mg

FABLE

Member
Joined
Jul 2, 2013
Messages
32
Brotizolam (marketed under brand name Lendormin) is a sedative-hypnotic thienotriazolodiazepine drug which is a benzodiazepine analog. It possesses anxiolytic, anticonvulsant, hypnotic, sedative and skeletal muscle relaxant properties, and is considered to be similar in effect to short-acting benzodiazepines such as triazolam. It is used in the short-term treatment of severe or debilitating insomnia. Brotizolam is an extremely potent drug and has shown anti-anxiety activity at doses as low as 0.08 to 0.1 milligrams, but the usual hypnotic dose of brotizolam is 0.125 to 0.25 milligrams,[7] and it is rapidly eliminated with an average half-life of 4.4 hours (range 3.6–7.9 hours).
The drug was developed by a team led by T. Nishiyama while working for Takeda Chemical Industries in 1976 in Japan.
Brotizolam is not approved for sale in the UK, United States or Canada. It is approved for sale in the Netherlands, Germany, Spain, Belgium, Luxembourg, Austria, Portugal, Israel, Italy, Taiwan and Japan.

Indications -
Brotizolam is prescribed for the short-term treatment, 2–4 weeks only of severe or debilitating insomnia. Insomnia can be described as a difficulty falling asleep, frequent awakening, early awakenings or a combination of each. Brotizolam is a short-acting benzodiazepine and is sometimes used in patients who have difficulty in maintaining sleep or getting to sleep. Hypnotics should only be used on a short-term basis or in those with chronic insomnia on an occasional basis.
Brotizolam, in a dose of 0.25 mg can be used as a premedication prior to surgery, this dose was found to be comparable in efficacy to 2 mg flunitrazepam as a premedicant prior to surgery.

Side effects -
Common side effects of brotizolam are typical of hypnotic benzodiazepines and are related to CNS depression, and include somnolence, ataxia, headache, anterograde amnesia, dizziness, fatigue, impairment of motor functions, slurred speech, confusion, and clumsiness.
Less common side effects include hypotension, respiratory depression, hallucinations, nausea and vomiting, palpitations, and paradoxical reactions (i.e. aggression, anxiety, violent behavior, etc.).
Brotizolam can cause residual side effects the next day such as impaired cognitive and motor functions as well as drowsiness. Disruption of sleep patterns may also occur such as suppression of REM sleep. These side effects are more likely at higher doses (above 0.5–1 mg).
In clinical trials brotizolam 0.125 to 0.5 mg improved sleep in insomniacs similarly to nitrazepam 2.5 and 5 mg, flunitrazepam 2 mg and triazolam 0.25 mg, whilst brotizolam 0.5 mg was shown to be superior to flurazepam 30 mg, but inferior to temazepam 30 mg in some studies. Brotizolam at dosages below 0.5 mg at night usually produced minimal morning drowsiness; no residual impairment of psychomotor performance occurs following dosages within the recommended range of 0.125 to 0.25 mg. No serious side effects have been reported to date and the most frequently observed adverse experiences are drowsiness, headache and dizziness. Mild rebound insomnia may occur in some patients when treatment is stopped.

Contraindications and special caution -
Thienodiazepines and benzodiazepines require special precaution if used in the elderly, during pregnancy, in children, alcohol or drug-dependent individuals and individuals with comorbid psychiatric disorders.

Pharmacology -
Brotizolam has been shown in animal studies to be a very high potency thienodiazepine. The elimination half-life of brotizolam is 3–6 hours. It is absorbed rapidly after administration; after administration, it is metabolized into active metabolites, one of which is far less potent than brotizolam and the other is only present in very small amounts in the blood and thus the metabolites of brotizolam do not have significant pharmacological effect in humans.[5] Brotizolam induces impairment of motor function and has hypnotic properties.
Brotizolam increases the slow wave light sleep (SWLS) in a dose-dependent manner whilst suppressing deep sleep stages. Less time is spent in stages 3 and 4 which are the deep sleep stages when GABAergics such as brotizolam are used. Benzodiazepines and thienodiazepines are therefore not ideal hypnotics in the treatment of insomnia. The suppression of deep sleep stages by either may be especially problematic to the elderly as they naturally spend less time in the deep sleep stage.

Abuse -
See also: Benzodiazepine drug misuse
Brotizolam is a drug with a potential for abuse. Drug misuse is defined as taking the drug to achieve a 'high', or continuing to take the drug in the long term against medical advice.
Abuse of brotizolam, although not widespread, was a problem in Hong Kong back in the late 1980s and 1990s. To control benzodiazepine abuse in Hong Kong, the Government's Pharmacy and Poisons Board reclassified benzodiazepines as Dangerous Drugs in October 1990. Apart from formal prescriptions, detailed records were then required for the supply and dispensing of these drugs. These regulations were applied initially only to brotizolam, triazolam and flunitrazepam as they were the major benzodiazepines of abuse. The impact of these regulatory changes on benzodiazepine use has been studied by analyzing the sales patterns of seven benzodiazepines between 1990–1993. In 1991, the sales of flunitrazepam and triazolam fell, but the sales of five unrestricted benzodiazepines increased. Particular problems arose with the trafficking and abuse of nimetazepam and the abuse of temazepam within that same year in 1991. The regulations that were originally only applied to brotizolam, triazolam and flunitrazepam were now being extended to include all benzodiazepines by January 1992. A regulation requiring the use of proper prescriptions and detailed records for the supply and dispensing of benzodiazepines, appears to have curbed, at least partially, their abuse in Hong Kong. There are still some problems with temazepam, nimetazepam, triazolam, and brotizolam, but they are not major.

 
There is only 2-3 vendors selling these meds anyway and they're in the email or invite only sections.

I'm sorry I never had time to read your whole post but any reviews on this med would be great.Ive read one I think which said they found them weak and felt let down by the effects?.

Bliss......

 
Drugbuyersguide Shoutbox
  1. xenxra @ xenxra: technically i'm aiming for $128k as a more precise near term target but 120k is cool too 🙃
  2. Dr-Octagon @ Dr-Octagon: Happy Fridays DBG!
  3. T @ timyboy: @xenxra indeed :) BTC seems to be climbing as well and your prediction of $120k seems spot on
  4. xenxra @ xenxra: @timyboy prob not gonna stall out til $3400
  5. CalFresh @ CalFresh: @hotdog45 & @Mokachin0 I am humbled by your kindness. thank you both so much for your generosity. This place is truly amazing.
  6. T @ timyboy: ETH going up!!
  7. H @ hotdog45: @Mokachin0 I cannot thank you enough for this act of kindness .
  8. M @ Mokachin0: @hotdog45 tight back at ya! What a generous idea in your response! But don’t forget, you just had your own tragedy, and still managed to put kindness into the world. That deserves recognition
  9. xenxra @ xenxra: @oh be g i have a 10 year track record, @CnC5 can vouch for me. intuition plus experience but don't hold me to it for 100% certainty.
  10. H @ hotdog45: @Mokachin0 oh my gosh I cannot thank you enough. This is so incredibly generous. Sending all the love I can your way, and everyone on this board love as well!
  11. M @ Mokachin0: @hotdog45 check your pms, thanks for your uplifting comment here, prize details in dm!
  12. T @ timyboy: Good Day!
  13. O @ oh be g: xenxra u know way more than me, why so ocnfident?
  14. T @ TheAZMan: @AaronRag sent. Thank you.
  15. A @ Aarfgh: @TheAZMan email admins using contact us button on bottom and ask, if you donated
  16. T @ TheAZMan: Who do I get the password protected forum login info?
  17. xenxra @ xenxra: monero is going to $700 in two-ish months. screenshot this as well.
  18. H @ hotdog45: Just wanted to send some love to everyone on this board. You guys have helped me through some difficult times and continue to. Thank you to everyone
  19. Strawhat7 @ Strawhat7: @xenxra got it! I figured as much but was strange that I could literally find no evidence that he was ever on here lol thought I was going nuts!
  20. xenxra @ xenxra: @Strawhat7 yeah he stopped sending out mags like last november or something iirc
Back
Top